Fructosamine

Home - Reagents - Fructosamine
reagents-logo

Key Benefits

Standardisation to the highest level

Our fructosamine calibrator and control is assigned relative to human serum glycated with 14C-glucose, thus standardisation is to the highest level and directly reflects the nature of the patient sample

Enzymatic Method

Offering improved specificity and reliability compared to conventional NBT-based methods. This method does not suffer from non-specific interferences unlike existing methods which can also be time consuming and difficult to automate

Excellent stability

Stable on board the analyser for 28 days at 10⁰C

Randox Fructosamine (Enzymatic)

  • Enzymatic method
  • Liquid ready-to-use reagents
  • Stable on board the analyser when stored at 10⁰C
  • Measuring range 8.12 – 1803 µmol/l
  • Fully automated applications
Cat NoSizeAnalyserEasy Read
Easy Fit
 
FR3133R1 5 x 25ml
R2 5 x 6.3ml
RX Daytona +/Monaco
RX Suzuka
Abbott Architect
Hitachi 917/Mod P
Konelab 20i/30i/60i
Beckman Coulter AU Series










FR4030R1 4 x 19.8ml
R2 4 x 6.9ml
RX Daytona/Imola
Hitachi 717/911/912/704/902


Instrument Specific Applications (ISA’s) are available for a wide range of biochemistry analysers.  Contact us to enquire about your specific analyser.

What is Fructosamine assay used for?

Serum fructosamine levels are elevated in diabetic patients with elevated blood glucose. When blood sugar levels are elevated, glucose binds to proteins such as albumin to form fructosamine, the concentration of which also increases.

Fructosamine is a much earlier indicator of diabetic control compared to HbA1c providing information on a person’s average blood glucose levels over the preceding 14-21 days. As such the American Diabetes Association recognises fructosamine as a useful tool in monitoring diabetes control.

Due to the shorter time span of fructosamine, it is also used to evaluate the effectiveness of medication changes and to monitor the treatment of gestational diabetes. The test is also particularly useful in situations where HbA1c cannot be reliably measured e.g. haemolytic anaemia, thalassemia or with genetic haemoglobin variants.

  • Gul, A., et al. Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications. Age (Dordr). 2008, 30(4): 303-309
Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
  • This field is for validation purposes and should be left unchanged.
×
Kit Insert Request - Reagents
×
Kit Insert Request - Reagents
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Reagents
×
Por favor, introduzca sus datos para ver nuestro último seminario
×